beta
Trial Radar IA

Mostrando gli studi clinici per Neoplasie che corrispondono al luogo: Francia.

Posso aiutarti a trovare studi clinici in località specifiche e offrire approfondimenti specialistici su condizioni di salute e trattamenti.

Con la modalità avanzata, puoi accedere a strumenti di preselezione potenti, visualizzazioni interattive e avvisi e-mail personalizzati sugli aggiornamenti degli studi.

Il nostro strumento di ricerca supporta solo l'inglese. Per la ricerca e la discussione in altre lingue, usa Trial Radar IA sopra o seleziona i filtri per condizione medica e luogo (qui sotto).
2.909 risultati trovati
Primi 50 visualizzati
 
Stato (Predefinito)
Non Ancora in Arruolamento, In Arruolamento, Attivo, Non in Arruolamento
×
 
Patologia
Neoplasie
×
 
Luogo
Francia
×
 
Titolo dello studio
Stato
Avelumab e metotrexato nelle neoplasie trofoblastiche gestazionali a basso rischio come trattamento di prima linea (TROPHAMET) NCT04396223
In arruolamento
Quality of Life Assessment for Early Identification of Supportive Care Needs in Oncology Patients (SOS-DETEQT) NCT06337487
Non ancora in arruolamento
Uno studio su GSK5733584 in combinazione con terapie antitumorali per tumori solidi avanzati (BEHOLD-2) NCT06796907
In arruolamento
Beamion PANTUMOR-1: uno studio per verificare se zongertinib aiuti le persone con tumori avanzati con alterazioni di HER2 NCT06581432
In arruolamento
A Study to Test Long-term Treatment With Brigimadlin in People With Solid Tumours Who Took Part in a Previous Study With This Medicine NCT06619509
Attivo, non in arruolamento
Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study (DAMeGe) NCT06589414
Attivo, non in arruolamento
A Study of Continued Treatment With Regorafenib in Participants With Solid Tumors Who Have Participated in Other Bayer Studies NCT06246643
Attivo, non in arruolamento
A Worldwide Cancer Registry Enrolling Participants Profiled With a Next-Generation Sequencing Test NCT04529122
In arruolamento
Evaluation of the Quality of Life and Tolerance of Patients Treated With Vectorized Internal Radiotherapy (RIV) for a Neuro Endocrine Tumor (NET) in the Auvergne-Rhône-Alpes Region. (AURA-RIV-TNE) NCT06043193
In arruolamento
Assessment and Prevention of Caregiver Burden in Oncology (PREPAC-01) NCT05750836
Non ancora in arruolamento
Monitoring of Neurological Symptoms, Treatment Tolerance, and Quality of Life Using the Resilience PRO Electronic Patient-reported Outcome Application in Patients With IDH-mutated Glioma (NEURO-PRO-GLIO) NCT07439302
Non ancora in arruolamento
Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation (GENEPSO) NCT03667417
In arruolamento
Optical Genome Mapping in Hematological Malignancies (CARTOGEN) NCT05009537
In arruolamento
Metagenomic Sequencing for the Identification of Pathogens in Febrile Neutropenic Patients (ADNEMIA) NCT06075888
In arruolamento
Evaluation of the Superficial Cervical Plexus Block in Oncological Throat and Neck Surgery (BCS-ORL) NCT07110857
Non ancora in arruolamento
Preparation for Medical and Surgical Procedures in Oncogeriatry. (PRIMECHO) NCT06443138
In arruolamento
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer NCT05204927
Attivo, non in arruolamento
Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery (COHEC2) NCT05197972
In arruolamento
Micro Assays for HemATology Malignancies Antibody Treatment (MAHATMAt) NCT07018310
Non ancora in arruolamento
Uno studio su patritumab deruxtecan in partecipanti pediatrici con tumori solidi recidivanti o refrattari (MK-9999-01C/LIGHTBEAM-U01) NCT06941272
In arruolamento
Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy (APALLO) NCT05379738
In arruolamento
Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO) NCT04707300
In arruolamento
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations (AcSé) NCT02304809
Attivo, non in arruolamento
Chronic Toxicities Related to Treatment in Patients With Localized Cancer (CANTO) NCT01993498
In arruolamento
Study and Follow-up of Multiple Endocrine Neoplasia Type 1 (GENEM) NCT03348501
In arruolamento
PACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of Treatments NCT06317389
In arruolamento
DEprescribing: Perceptions of PAtients Living With Advanced Cancer (DEPAL) NCT06193083
In arruolamento
Puxitatug samrotecan (azd8205) monoterapia rispetto alla chemioterapia nel carcinoma endometriale selezionato b7-h4 (bluestar-endometrial01) NCT07044336
In arruolamento
Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI) (POSALLO) NCT06541067
In arruolamento
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy of Immunotherapy in Patients With Early Stage Cancer (MINER2) NCT07427186
Non ancora in arruolamento
Observational Study Protocol: LIVER-R NCT06252753
In arruolamento
Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies (AROM-HEMATO) NCT06150469
In arruolamento
Fertility and Pregnancy After Avelumab Treatment (FERTILAVE) NCT06242522
Non ancora in arruolamento
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy (MINER) NCT03514368
In arruolamento
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide NCT05768035
In arruolamento
Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence (STEREO-RE-PRO) NCT03438552
Attivo, non in arruolamento
Evaluation of Positron Emission Tomography (PET) With [18F]FET for the Detection of ACTH-Secreting Corticotroph Pituitary Neuroendocrine Tumors. (PiTFET) NCT07463625
In arruolamento
Prospective Cohort With Hemopathy in Languedoc-Roussillon (HemoDiag) NCT02134574
In arruolamento
Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies NCT04164199
Attivo, non in arruolamento
Immunological Impact of a Post Cell Therapy Treatment With FLT3 Inhibitors (TARGETALLO) NCT06992934
Non ancora in arruolamento
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) NCT06923761
In arruolamento
Imaging and Evolution of Pigmented Tumors of the Anterior Ocular System in Children NCT07120178
In arruolamento
Assessment of the Impact of Increased Production of Reactive Oxygen Species Produced During Repeated Sessions of Hyperbaric Oxygen Therapy in Patients Undergoing Radiotherapy for Neoplasia, on the Occurrence of DNA Damage (OXYBAR) NCT06999785
Non ancora in arruolamento
Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases (LUTARTERIAL) NCT04837885
In arruolamento
Uno studio su teclistamab in partecipanti con mieloma multiplo recidivante o refrattario (MajesTEC-1) NCT04557098
Attivo, non in arruolamento
Clinical Efficacy of Platelet Transfusion (ECLAT) NCT06805097
In arruolamento
Uno studio su talquetamab in partecipanti con mieloma multiplo recidivante o refrattario (MonumenTAL-1) NCT04634552
In arruolamento
Studio di escalation della dose di teclistamab, un anticorpo bispecifico umanizzato BCMA*CD3, in partecipanti con mieloma multiplo recidivante o refrattario (MajesTEC-1) NCT03145181
Attivo, non in arruolamento
A Study of GSK5764227 in Participants With. Advanced Solid Tumors (EMBOLD PanTumor-101) NCT06551142
In arruolamento
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms NCT06150157
In arruolamento